# Study to Assess the Safety and Efficacy of an IT Administration of SCM-010 in SPMS

> **NCT03696485** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Stem Cell Medicine Ltd.**

## Conditions studied

- Secondary Progressive Multiple Sclerosis (SPMS)

## Interventions

- **BIOLOGICAL:** SCM-010

## Key facts

- **NCT ID:** NCT03696485
- **Lead sponsor:** Stem Cell Medicine Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-02-01
- **Primary completion:** 2025-02-01
- **Final completion:** 2025-02-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Due to sponsor decision
- **Last updated:** 2024-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03696485

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03696485, "Study to Assess the Safety and Efficacy of an IT Administration of SCM-010 in SPMS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03696485. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*